Main Session
Sep
27
SS 03 - Technologically Driven strategies in HPVrelated OPSCC
110 - Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer Demonstrating Reduced Toxicity with Durable Long-Term Control
Presenter(s)
Nancy Lee, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York, NY